. Oligonucleotide microarray hybridization analysis of faecal molecules identified gene transcripts differentially present in faeces. In conclusion, faecal RPL19 expression is associated with advanced tumour stages and addictive to serum CEA in predicting prognosis of CRC patients.
Introduction
Cancer development and progression involve a complex process with multiple genetic changes [1] . Genome-wide approaches have accelerated the large-scale discovery of cancer-related molecules [2] [3] [4] , including genes with altered expression, in a variety of malignant tumours [5, 6] . In colorectal cancer (CRC), a predominant gastrointestinal malignancy and multi-gene disease [7] [8] [9] , clarification of the roles of oncogenes and other genes responsible for tumourigenesis is critical for the development of therapeutic strategies [10] .
Ribosomal proteins (RPs) are a major component of the ribosome, and are involved in the cellular process of translation [11] . Their activity is required for the growth and maintenance of all cell types [12] . Deregulation of the molecular mechanisms controlling cell growth can alter cell sizes, and may contribute to a variety of pathological conditions, including cancer [13] . Therefore, genes for RPs might be 'cancer genes' in humans, reflecting the potential importance of ribosomal function and translational control in tumour progression [14, 15] . Many studies have evaluated specific RPs in some gastrointestinal malignancies [16, 17] . Thus, the role of RPs in cancer prevention, prognosis prediction and therapy is becoming increasingly important.
Recent studies suggested that a molecular test of faecal material might elucidate the molecular pathogenesis of CRC [18] [19] [20] . In our previously faecal studies, we used advanced microarray technology to define global changes in gene expression detectable in faeces [21] and found many RPs were differentially expressed. Changes in the expression of a series of RPs were demonstrated in CRC patients [16, 22] . In addition, one of RPs, ribosomal protein L19 (RPL19), was up-regulated in human breast tumours [23] . Overexpression of this protein is also considered to be a valuable marker in prostate cancer diagnosis and patient management [24] . Accordingly years old) were obtained and preserved in specific preservation buffer until total RNA was purified as described in our previous report [25] . 
Oligonucleotide microarray hybridization and data extraction
The methods for synthesizing fluorescently labelled cRNA, microarray hybridizations, and data extraction were described in our previous report [21] . The quantified signal and background intensity for each transcript were substantially normalized using the rank-consistency-filtering LOWESS method [30] [31] . Average-linkage hierarchical clustering of an uncentered Detection of RPL19 expression levels in cell lines, tissues, and faecal samples
. Significant differences in the expression of faecal gene products between groups (healthy controls and patients at different Dukes' stages) were identified with Student's t-test (Ն twofold differences, P < 0.01). Statistical comparisons were made with the highest mean intensities
All cDNAs were generated as previously described [18, 21] . (Fig. 1B) .
Quantitation of RPL19 expression in colon cell lines and CRC tissues
The expressions of RPL19 from colon cell lines were quantified by real-time PCR with RPL19-specific primers. As shown in Fig. 2 [34] . This risk rises sharply at the age of 50-55 years [35] . However, the survival of patients with CRC is closely related to its early detection [36] and the mortality rate would decrease with access to regular high-quality screening [34] . Therefore, the identification of candidate markers for CRC has become an importantly preventative strategy. [10, 37] . Recent studies suggested that the molecular analysis of faecal material elucidates the molecular pathogenesis of CRC [19, 38] .
Discussion

CRC is one of the commonest causes of cancer death among men of 40-79 years and older
Since CRC is a molecular genetic disease, the recognition of cancer genes and the direct quantification of their expression in colonic cells will be a key to the development of successful therapies and the earlier detection of CRC
Further, the fact that exfoliated colonic cells in faeces can be isolated and cultured implies the clinical utility of faeces in noninvasive CRC screening with molecular approaches [39, 40] . These cells provide a diverse class of candidate faecal markers to distinguish colorectal neoplasia from normal [41] . Faecal analysis showed that the expression of many genes is altered in CRC patients at different Dukes' stages [37, 42, 43] . Therefore, the direct evaluation of exfoliated colonocytes should demonstrate the potential of faeces as a useful platform for CRC-associated biomarkers on target cells [37, 44] . [18, 25] . In our studies, we used advanced microarray technology to define global changes in gene expression in faeces [21] . Vogelstein et al. reported that CRC progression is driven by the accumulation of genetic changes and consequent changes in gene expression patterns [9] . Therefore, genes identified as having altered expression patterns in the faecal colonic cells provide non-invasive targets for early diagnosis, CRC treatment strategies and prognostic indicators.
In this study, we identified a series of RPs with altered expression in the faeces of CRC patients using oligonucleotide microarray hybridization. Recently, many RP genes have been shown to be cancer genes in zebrafish [14] . An increasing number of RPs have been studied as cancer-related molecules by others. These studies have included examinations of the role of RPS3 in the onset of cancer [45] , the promotion by RPS13 or RPL23 of multidrug resistance in gastric cancer [17] and the contribution of RPL36 to the multi-factorial mechanisms of cisplatin resistance [46] . The genes for RPS7, RPL23, RPL11, RPL5, RPL26 and RPS27L were also shown to be p53-related molecules [47, 48] .
Reports of RPL19 were few until Bee et al. recently demonstrated its overexpression in patients with malignant prostate cancer, and showed its association with shorter patient survival [24] . RPL19 is also co-expressed with ErbB-2 in breast cancer [23, 49] [51] . The clinical significance of most mitochondrial RPs warrants investigation.
Gene expression profiling analysis using microarray technology has been widely applied to the classification of cancers at the molecular level [52] . qRT-PCR is often used to confirm the findings of microarray analyses [53] . We first used these two advanced approaches to characterize molecules detectable in faeces. It 
